(Q36303837)

13 August 2017

1 reference

title

Long-term survivors of childhood cancers: what knowledge have we gained? (English)

1 reference

13 August 2017

Mike M Hawkins

1

1 reference

13 August 2017

publication date

1 November 2004

1 reference

Nature Clinical Practice Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

1

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

26-31

1 reference

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Late deaths and survival after childhood cancer: implications for cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Incidence of second primary tumours among childhood cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Second primary neoplasms in patients with retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Anthracycline-induced cardiotoxicity in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Anthracycline cardiotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Cranial irradiation and central hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Childhood cancer survival in Europe and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Long-term follow-up of survivors of childhood cancer in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

Long term survival and cure after childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Late deaths after treatment for childhood cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Lifetime risks of common cancers among retinoblastoma survivors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Second cancers following pediatric Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Cardiac disease following treatment of Hodgkin's disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0020

7 January 2021

Identifiers

DOI

10.1038/NCPONC0020

1 reference

13 August 2017

1 reference